» Articles » PMID: 30558110

Suppression of Type I Interferon Signaling by NS5

Overview
Journal Viruses
Publisher MDPI
Specialty Microbiology
Date 2018 Dec 19
PMID 30558110
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Type I interferon (IFN-I) is the first line of mammalian host defense against viral infection. To counteract this, the flaviviruses, like other viruses, have encoded a variety of antagonists, and use a multi-layered molecular defense strategy to establish their infections. Among the most potent antagonists is non-structural protein 5 (NS5), which has been shown for all disease-causing flaviviruses to target different steps and players of the type I IFN signaling pathway. Here, we summarize the type I IFN antagonist mechanisms used by flaviviruses with a focus on the role of NS5 in regulating one key regulator of type I IFN, signal transducer and activator of transcription 2 (STAT2).

Citing Articles

Dengue Virus Infection: Immune Response and Therapeutic Targets.

Tin Ern N, Komarasamy T, Adnan N, Balasubramaniam V Am J Trop Med Hyg. 2024; 112(1):37-44.

PMID: 39531732 PMC: 11720763. DOI: 10.4269/ajtmh.23-0545.


Etravirine Prevents West Nile Virus and Chikungunya Virus Infection Both In Vitro and In Vivo by Inhibiting Viral Replication.

Zheng X, He Y, Xia B, Tang W, Zhang C, Wang D Pharmaceutics. 2024; 16(9).

PMID: 39339151 PMC: 11435157. DOI: 10.3390/pharmaceutics16091111.


Zika virus NS5 protein inhibits type I interferon signaling via CRL3 E3 ubiquitin ligase-mediated degradation of STAT2.

Ren W, Fu C, Zhang Y, Ju X, Jiang X, Song J Proc Natl Acad Sci U S A. 2024; 121(34):e2403235121.

PMID: 39145933 PMC: 11348293. DOI: 10.1073/pnas.2403235121.


Integrated control strategies for dengue, Zika, and Chikungunya virus infections.

Cortes N, Lira A, Prates-Syed W, Dinis Silva J, Vuitika L, Cabral-Miranda W Front Immunol. 2024; 14:1281667.

PMID: 38196945 PMC: 10775689. DOI: 10.3389/fimmu.2023.1281667.


Tick-borne flavivirus NS5 antagonizes interferon signaling by inhibiting the catalytic activity of TYK2.

Gracias S, Chazal M, Decombe A, Unterfinger Y, Sogues A, Pruvost L EMBO Rep. 2023; 24(12):e57424.

PMID: 37860832 PMC: 10702846. DOI: 10.15252/embr.202357424.


References
1.
Zhao B, Yi G, Du F, Chuang Y, Vaughan R, Sankaran B . Structure and function of the Zika virus full-length NS5 protein. Nat Commun. 2017; 8:14762. PMC: 5378950. DOI: 10.1038/ncomms14762. View

2.
He Z, Zhu X, Wen W, Yuan J, Hu Y, Chen J . Dengue Virus Subverts Host Innate Immunity by Targeting Adaptor Protein MAVS. J Virol. 2016; 90(16):7219-7230. PMC: 4984625. DOI: 10.1128/JVI.00221-16. View

3.
Kumar A, Hou S, Airo A, Limonta D, Mancinelli V, Branton W . Zika virus inhibits type-I interferon production and downstream signaling. EMBO Rep. 2016; 17(12):1766-1775. PMC: 5283583. DOI: 10.15252/embr.201642627. View

4.
Ousman S, Wang J, Campbell I . Differential regulation of interferon regulatory factor (IRF)-7 and IRF-9 gene expression in the central nervous system during viral infection. J Virol. 2005; 79(12):7514-27. PMC: 1143633. DOI: 10.1128/JVI.79.12.7514-7527.2005. View

5.
Best S, Morris K, Shannon J, Robertson S, Mitzel D, Park G . Inhibition of interferon-stimulated JAK-STAT signaling by a tick-borne flavivirus and identification of NS5 as an interferon antagonist. J Virol. 2005; 79(20):12828-39. PMC: 1235813. DOI: 10.1128/JVI.79.20.12828-12839.2005. View